Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRE-EMPT
2013-001984-21Phase 4Unknown
- Sponsor
- University of Aberdeen
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of avatrombopag, medroxyprogesterone acetate and ethinylestradiol + levonorgestrel in endometriosis (4 arms), sponsored by University of Aberdeen. Primary endpoints: Recurrence of symptoms by EHP-30 pain domain and EHP-30 pain domain over time. Status: unknown.
02
Drugs
avatrombopagmedroxyprogesterone acetateethinylestradiol + levonorgestrel
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2013-001984-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001984-21.